There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:CPC A61K31/40
Pages in category "CPC A61K31/40"
The following 35 pages are in this category, out of 35 total.
2
- 20250152555. Pharmaceutic (Daewoong Pharmaceutical ., .)
- 20250152555. Pharmaceutic (Daewoong Pharmaceutical Co., Ltd.)
- 20250170096. Oxphos Inhibitors (ImmunoMet Therapeutics, .)
- 20250177349. Aryl Alkynamide Derivati (Astellas Pharma, .)
- 20250177350. Compositions (Janssen Pharmaceuticals, .)
- 20250186393. Treatment Breast Cancer Amcenes (SANOFI)
- 20250186394. Use Amisulpride As (ACACIA PHARMA LIMITED)
- 20250186395. Glycopyrrolate Sal (Journey Medical)
- 20250205195. Benzyloxy-benzylaminyl Amin (AMTIXBIO ., .)
- 20250213526. Triple Uptake Inhibitor Th (Noema Pharma AG)
- 20250228818. Pharmaceutical Combination Containing Capsid Protein Inhibitor Reverse Transcriptase Inhibi (CHIA TAI TIANQING PHARMACEUTICAL GROUP ., .)
- 20250228819. Compositions Com (Janssen Pharmaceuticals, .)
B
D
S
T
- THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM Patent Application Trends in 2024
- The Board of Regents of the University of Texas System Patent Application Trends in 2024
- The Regents of The University Of California Patent Application Trends in 2024
- THE REGENTS OF THE UNIVERSITY OF CALIFORNIA Patent Application Trends in 2024